Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required

palivizumab [Palivizumab]

tematický
13
Termíny

Synagis

 

MEDI 493
MEDI-493
Monoclonal Antibody MEDI-493
Synagis

Perzistentní odkaz   https://www.medvik.cz/link/D000069455
Definice

A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.

DUI
D000069455 MeSH Prohlížeč
CUI
M0288015
Historická pozn.
2016 (1998)
Veřejná pozn.
2016; PALIVIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015

D Chemikálie a léčiva
D12.776 proteiny 2 587
D12.776.124 krevní proteiny 911
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 494
D12.776.124.486.485.114 protilátky 1 818
D12.776.124.486.485.114.224 monoklonální protilátky 4 704
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 960
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 357
D12.776.124.486.485.114.224.060.313 alemtuzumab 125
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 456
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 45
D12.776.124.486.485.114.224.060.500 certolizumab pegol 49
D12.776.124.486.485.114.224.060.750 cetuximab 186
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 158
D12.776.124.486.485.114.224.060.790 gemtuzumab 19
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 267
D12.776.124.486.485.114.224.060.813 natalizumab 158
D12.776.124.486.485.114.224.060.829 nivolumab 461
D12.776.124.486.485.114.224.060.844 omalizumab 115
D12.776.124.486.485.114.224.060.860 palivizumab 13
D12.776.124.486.485.114.224.060.864 panitumumab 62
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 63
D12.776.124.486.485.114.224.060.875 trastuzumab 278
D12.776.124.486.485.114.224.060.937 ustekinumab 125
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 494
D12.776.124.790.651.114 protilátky 1 818
D12.776.124.790.651.114.224 monoklonální protilátky 4 704
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 960
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 357
D12.776.124.790.651.114.224.060.375 alemtuzumab 125
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 456
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 45
D12.776.124.790.651.114.224.060.500 certolizumab pegol 49
D12.776.124.790.651.114.224.060.750 cetuximab 186
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 158
D12.776.124.790.651.114.224.060.790 gemtuzumab 19
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 267
D12.776.124.790.651.114.224.060.813 natalizumab 158
D12.776.124.790.651.114.224.060.829 nivolumab 461
D12.776.124.790.651.114.224.060.844 omalizumab 115
D12.776.124.790.651.114.224.060.860 palivizumab 13
D12.776.124.790.651.114.224.060.864 panitumumab 62
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 63
D12.776.124.790.651.114.224.060.875 trastuzumab 278
D12.776.124.790.651.114.224.060.937 ustekinumab 125
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 494
D12.776.377.715.548.114 protilátky 1 818
D12.776.377.715.548.114.224 monoklonální protilátky 4 704
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 960
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 357
D12.776.377.715.548.114.224.200.375 alemtuzumab 125
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 456
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 45
D12.776.377.715.548.114.224.200.500 certolizumab pegol 49
D12.776.377.715.548.114.224.200.750 cetuximab 186
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 158
D12.776.377.715.548.114.224.200.790 gemtuzumab 19
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 267
D12.776.377.715.548.114.224.200.813 natalizumab 158
D12.776.377.715.548.114.224.200.829 nivolumab 461
D12.776.377.715.548.114.224.200.844 omalizumab 115
D12.776.377.715.548.114.224.200.860 palivizumab 13
D12.776.377.715.548.114.224.200.864 panitumumab 62
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 63
D12.776.377.715.548.114.224.200.875 trastuzumab 278
D12.776.377.715.548.114.224.200.937 ustekinumab 125